Status:
COMPLETED
FoundationOne™ Test Registry Study
Lead Sponsor:
Foundation Medicine
Collaborating Sponsors:
Quintiles, Inc.
Conditions:
Cancer
Neoplasm Metastasis
Eligibility:
All Genders
18+ years
Brief Summary
This study is a prospective, multicenter, observational study to characterize utilization patterns of the FoundationOne™ test by oncologists under conditions of routine clinical practice in the US. Th...
Detailed Description
Molecular testing of tumors, using techniques such as next-generation sequencing (NGS), facilitates an individualized approach to cancer treatment by sub-classifying diseases on an individual basis. P...
Eligibility Criteria
Inclusion
- The FoundationOne test was ordered by the treating physician under routine clinical practice
- Age ≥ 18 years
- Patient willing and able to provide informed consent
- Informed consent date is at least one day prior to the FoundationOne test report date
Exclusion
- There are no exclusion criteria for this study
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
510 Patients enrolled
Trial Details
Trial ID
NCT01851213
Start Date
March 1 2013
End Date
March 1 2016
Last Update
August 9 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Evergreen Hematology/Oncology
Spokane, Washington, United States, 99218